img

Global Critical Care Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Critical Care Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Critical Care Therapeutics market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Critical Care Therapeutics market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Critical Care Therapeutics in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates

Market Snapshot, By Application
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Others

Main Market Players Analyzed in this report, including
Thermo Fisher Scientific
Takeda
Shanghai RAAS
Rockwell Medical
REVO Biologics
Octapharma
Mitsubishi Tanabe Pharma
Merck
King Pharmaceuticals
Kedrion Biopharma
Grifols
CSL Behring
Cosmo Pharmaceuticals
China Biologic Products
Bayer HealthCare

The study objectives of this report are
To study and analyze the global Critical Care Therapeutics market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Critical Care Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Critical Care Therapeutics manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Critical Care Therapeutics market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Critical Care Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Critical Care Therapeutics are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Critical Care Therapeutics Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Critical Care Therapeutics Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Critical Care Therapeutics

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Pulmonary Embolism (PE)
3.2.2 Major Buyers in Acute Coronary Syndrome

4 Market Segment: by Type
4.1 Critical Care Therapeutics Type Introduction
4.1.1 Albumin
4.1.2 Prothrombin Complex Concentrates
4.1.3 Antithrombin Concentrates
4.1.4 Factor XIII Concentrates
4.1.5 Fibrinogen Concentrates
4.2 Global Critical Care Therapeutics Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Critical Care Therapeutics Type Introduction
5.1.1 Pulmonary Embolism (PE)
5.1.2 Acute Coronary Syndrome
5.1.3 Atrial Fibrillation
5.1.3 Others
5.2 Global Critical Care Therapeutics Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Critical Care Therapeutics Market by Region
6.2 North America Critical Care Therapeutics Market 2016-2021
6.3 Europe Critical Care Therapeutics Market 2016-2021
6.4 Asia Pacific Critical Care Therapeutics Market 2016-2021
6.5 South America Critical Care Therapeutics Market 2016-2021
6.6 Middle East and Africa Critical Care Therapeutics Market 2016-2021

7 North America
7.1 North America Critical Care Therapeutics Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Critical Care Therapeutics Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Critical Care Therapeutics Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Critical Care Therapeutics Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Critical Care Therapeutics Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Information
12.1.2 Thermo Fisher Scientific Critical Care Therapeutics Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific Key Development
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Critical Care Therapeutics Product Portfolio, Specification and Application
12.2.3 Takeda Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.2.4 Takeda Key Development
12.3 Shanghai RAAS
12.3.1 Shanghai RAAS Company Information
12.3.2 Shanghai RAAS Critical Care Therapeutics Product Portfolio, Specification and Application
12.3.3 Shanghai RAAS Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.3.4 Shanghai RAAS Key Development
12.4 Rockwell Medical
12.4.1 Rockwell Medical Company Information
12.4.2 Rockwell Medical Critical Care Therapeutics Product Portfolio, Specification and Application
12.4.3 Rockwell Medical Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.4.4 Rockwell Medical Key Development
12.5 REVO Biologics
12.5.1 REVO Biologics Company Information
12.5.2 REVO Biologics Critical Care Therapeutics Product Portfolio, Specification and Application
12.5.3 REVO Biologics Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.5.4 REVO Biologics Key Development
12.6 Octapharma
12.6.1 Octapharma Company Information
12.6.2 Octapharma Critical Care Therapeutics Product Portfolio, Specification and Application
12.6.3 Octapharma Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.6.4 Octapharma Key Development
12.7 Mitsubishi Tanabe Pharma
12.7.1 Mitsubishi Tanabe Pharma Company Information
12.7.2 Mitsubishi Tanabe Pharma Critical Care Therapeutics Product Portfolio, Specification and Application
12.7.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.7.4 Octapharma Key Development
12.9 King Pharmaceuticals
12.9.1 King Pharmaceuticals Company Information
12.9.2 King Pharmaceuticals Critical Care Therapeutics Product Portfolio, Specification and Application
12.9.3 King Pharmaceuticals Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.9.4 King Pharmaceuticals Key Development
12.8 Merck
12.8.1 Merck Company Information
12.8.2 Merck Critical Care Therapeutics Product Portfolio, Specification and Application
12.8.3 Merck Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.8.4 Merck Key Development
12.11 Grifols
12.11.1 Grifols Company Information
12.11.2 Grifols Critical Care Therapeutics Product Portfolio, Specification and Application
12.11.3 Grifols Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.11.4 Grifols Key Development
12.12 CSL Behring
12.12.1 CSL Behring Company Information
12.12.2 CSL Behring Critical Care Therapeutics Product Portfolio, Specification and Application
12.12.3 CSL Behring Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.12.4 CSL Behring Key Development
12.13 Cosmo Pharmaceuticals
12.13.1 Cosmo Pharmaceuticals Company Information
12.13.2 Cosmo Pharmaceuticals Critical Care Therapeutics Product Portfolio, Specification and Application
12.13.3 Cosmo Pharmaceuticals Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.13.4 Cosmo Pharmaceuticals Key Development
12.14 China Biologic Products
12.14.1 China Biologic Products Company Information
12.14.2 China Biologic Products Critical Care Therapeutics Product Portfolio, Specification and Application
12.14.3 China Biologic Products Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.14.4 China Biologic Products Key Development
12.15 Bayer HealthCare
12.15.1 Bayer HealthCare Company Information
12.15.2 Bayer HealthCare Critical Care Therapeutics Product Portfolio, Specification and Application
12.15.3 Bayer HealthCare Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
12.15.4 Bayer HealthCare Key Development

13 Global Critical Care Therapeutics Market Forecast by Region by Type and by Application
13.1 Global Critical Care Therapeutics Revenue Forecast 2022-2027
13.2 Global Critical Care Therapeutics Forecast by Regions
13.3 Global Critical Care Therapeutics Forecast by Type
13.4 Global Critical Care Therapeutics Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Critical Care Therapeutics Production Specifications
Table 2: Drivers in Critical Care Therapeutics Market
Table 3: Restraints Critical Care Therapeutics Market
Table 4: Opportunity in Critical Care Therapeutics Market
Table 5: Comparion of Alternative and Critical Care Therapeutics
Table 6: Critical Care Therapeutics Raw Materials Key Suppliers List
Table 7: Critical Care Therapeutics Distributors List
Table 8: Critical Care Therapeutics Major Buyers in Application One
Table 9: Critical Care Therapeutics Major Buyers in Application Two
Table 10: Critical Care Therapeutics Major Buyers in Application Three
Table 11: Global Critical Care Therapeutics Revenue (Million USD) by Type 2016-2021
Table 12: Global Critical Care Therapeutics Revenue Market Share by Type 2016-2021
Table 18: Global Critical Care Therapeutics Revenue (Million USD) by Application 2016-2021
Table 19: Global Critical Care Therapeutics Revenue Market Share by Application 2016-2021
Table 20: Global Critical Care Therapeutics Revenue (Million USD) by Region 2016-2021
Table 21: Global Critical Care Therapeutics Revenue Market Share by Region 2016-2021
Table 22: North America Critical Care Therapeutics Revenue (Million USD) by Country 2016-2021
Table 23: North America Critical Care Therapeutics Revenue Market Share by Country 2016-2021)
Table 24: Europe Critical Care Therapeutics Revenue (Million USD) by Country 2016-2021
Table 25: Europe Critical Care Therapeutics Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Critical Care Therapeutics Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Critical Care Therapeutics Revenue Market Share by Country 2016-2021)
Table 28: South America Critical Care Therapeutics Revenue (Million USD) by Country 2016-2021
Table 29: South America Critical Care Therapeutics Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Critical Care Therapeutics Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Critical Care Therapeutics Revenue Market Share by Country 2016-2021)
Table 32 Thermo Fisher Scientific Company Information
Table 33 Thermo Fisher Scientific Critical Care Therapeutics Product Portfolio, Specification and Application
Table 34 Thermo Fisher Scientific Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 35 Takeda Company Information
Table 36 Takeda Critical Care Therapeutics Product Portfolio, Specification and Application
Table 37 Takeda Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 38 Shanghai RAAS Company Information
Table 39 Shanghai RAAS Critical Care Therapeutics Product Portfolio, Specification and Application
Table 40 Shanghai RAAS Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 41 Rockwell Medical Company Information
Table 42 Rockwell Medical Critical Care Therapeutics Product Portfolio, Specification and Application
Table 43 Rockwell Medical Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 44 REVO Biologics Company Information
Table 45 REVO Biologics Critical Care Therapeutics Product Portfolio, Specification and Application
Table 46 REVO Biologics Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 47 Octapharma Company Information
Table 48 Octapharma Critical Care Therapeutics Product Portfolio, Specification and Application
Table 49 Octapharma Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 50 Mitsubishi Tanabe Pharma Company Information
Table 51 Mitsubishi Tanabe Pharma Critical Care Therapeutics Product Portfolio, Specification and Application
Table 52 Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 53 Merck Company Information
Table 54 Merck Critical Care Therapeutics Product Portfolio, Specification and Application
Table 55 Merck Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 56 King Pharmaceuticals Company Information
Table 57 King Pharmaceuticals Critical Care Therapeutics Product Portfolio, Specification and Application
Table 58 King Pharmaceuticals Critical Care Therapeutics Revenue and Gross Margin (2019-2021)
Table 59: Global Critical Care Therapeutics Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Critical Care Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Critical Care Therapeutics Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Critical Care Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Critical Care Therapeutics Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Critical Care Therapeutics Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Critical Care Therapeutics Picture
Figure 2: Global Critical Care Therapeutics Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Critical Care Therapeutics Industry Life Cycle
Figure 5: Product Picture of Albumin
Figure 6: Product Picture of Prothrombin Complex Concentrates
Figure 9: Global Critical Care Therapeutics Revenue Market Share by Type, 2020
Figure 10: Critical Care Therapeutics in Pulmonary Embolism (PE)
Figure 11: Global Critical Care Therapeutics Market: Pulmonary Embolism (PE) 2016-2021
Figure 12: Critical Care Therapeutics in Acute Coronary Syndrome
Figure 13: Global Critical Care Therapeutics Market: Acute Coronary Syndrome 2016-2021
Figure 14: Global Critical Care Therapeutics Revenue Market Share by Application, 2020
Figure 15: Global Critical Care Therapeutics Revenue Market Share by Region 2016-2021
Figure 16: North America Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 7: Europe Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 8: Asia Pacific Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 9: South America Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 10: Middle East and Africa Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 11: North America Critical Care Therapeutics Revenue Market Share by Country, 2020
Figure 12: United States Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 13: Canada Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 14: Mexico Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 15: Europe Critical Care Therapeutics Revenue Market Share by Country, 2020
Figure 16: Germany Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 17: France Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 18: UK Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 19: Italy Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 20: Russia Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 21: Spain Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Critical Care Therapeutics Revenue Market Share by Country, 2020
Figure 23: China Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 24: Japan Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 25: Korea Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 26: Southeast Asia Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 27: India Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 28: Australia Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 29: South America Critical Care Therapeutics Revenue Market Share by Country, 2020
Figure 30: Brazil Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 31: Argentina Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 32: Colombia Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 33: Middle East and Africa Critical Care Therapeutics Revenue Market Share by Country, 2020
Figure 34: Turkey Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 35: Saudi Arabia Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 36: South Africa Critical Care Therapeutics Revenue (Million USD) Status 2016-2021
Figure 37: Thermo Fisher Scientific Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 38: Takeda Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 39: Shanghai RAAS Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 40: Rockwell Medical Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 41: REVO Biologics Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 42: Octapharma Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 43: Mitsubishi Tanabe Pharma Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 44: Merck Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 45: King Pharmaceuticals Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 46: Kedrion Biopharma Critical Care Therapeutics Revenue Market Share Globally (2019-2021)
Figure 47: Global Critical Care Therapeutics Revenue (Million USD) Forecast (2022-2027)

Select User License

$3980 Single Licence
$5950 Enterprise Licence
$7960 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries